{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:50:30Z","timestamp":1791867030657,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.phrs.2012.02.012","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T11:30:52Z","timestamp":1331206252000},"page":"553-563","source":"Crossref","is-referenced-by-count":88,"title":["Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions"],"prefix":"10.1016","volume":"65","author":[{"given":"Oscar","family":"Sasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Bertorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Colombano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Moreno-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2012.02.012_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.phrs.2012.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2012.02.012_bib0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.phrs.2012.02.012_bib0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2012.02.012_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0030","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MCO.0b013e3282f00061","article-title":"Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players","volume":"10","author":"Lambert","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.phrs.2012.02.012_bib0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2010.03.022","article-title":"Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain","volume":"224","author":"Hansen","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0040","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1021\/jm800311k","article-title":"Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors","volume":"51","author":"Seierstad","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.phrs.2012.02.012_bib0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.phrs.2012.02.012_bib0050","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm031140x","article-title":"Cyclohexylcarbamic acid 3\u2032- or 4\u2032-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies","volume":"47","author":"Mor","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.phrs.2012.02.012_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.phrs.2012.02.012_bib0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective FAAH inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2012.02.012_bib0065","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2012.02.012_bib0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice","volume":"322","author":"Russo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2012.02.012_bib0075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.phrs.2012.02.012_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2011.07.001","article-title":"ABCG2 (BCRP) restricts access of FAAH inhibitor URB937 to the central nervous system","volume":"64","author":"Moreno-Sanz","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phrs.2012.02.012_bib0085","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/jm070352h","article-title":"Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity","volume":"51","author":"Qin","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.phrs.2012.02.012_bib0090","unstructured":"Reed MJ, Potter BVL US2006\/0241173."},{"key":"10.1016\/j.phrs.2012.02.012_bib0095","unstructured":"Fay LK, Johnson DS, Kesten SR, Lazerwith SE, Morris MA, Stiff CM, et al. US2008\/0261941."},{"key":"10.1016\/j.phrs.2012.02.012_bib0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/ml100190t","article-title":"Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor","volume":"2","author":"Johnson","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.phrs.2012.02.012_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2012.02.012_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2012.02.012_bib0115","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0022-3565(25)10713-1","article-title":"Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach","volume":"3","author":"Chan","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2012.02.012_bib0120","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/S0024-3205(02)01549-7","article-title":"Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects","volume":"70","author":"Jain","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2012.02.012_bib0125","series-title":"Drug synergism and dose-effect data analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.phrs.2012.02.012_bib0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.108.143487","article-title":"Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception","volume":"329","author":"Naidu","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2012.02.012_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","article-title":"Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract","volume":"24","author":"Sostres","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-3-540-79090-7_14","article-title":"Opioids and sensory nerves","volume":"194","author":"Stein","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2012.02.012_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2012.02.012_bib0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.phrs.2012.02.012_bib0160","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.phrs.2012.02.012_bib0165","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.phrs.2012.02.012_bib0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000235870","article-title":"Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report","volume":"43","author":"Kaufmann","year":"2009","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.phrs.2012.02.012_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-006-0250-x","article-title":"The fatty acid amide hydrolase 385 A\/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction","volume":"120","author":"Flanagan","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.phrs.2012.02.012_bib0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/tpj.2009.59","article-title":"Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1","volume":"10","author":"Proudnikov","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.phrs.2012.02.012_bib0185","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1171870","article-title":"Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization","volume":"325","author":"Pern\u00eda-Andrade","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2012.02.012_bib0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2007.00512.x","article-title":"Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation","volume":"217","author":"Boyce","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.phrs.2012.02.012_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(02)02485-8","article-title":"A role for endocannabinoids in indomethacin-induced spinal antinociception","volume":"454","author":"G\u00fchring","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.08.013","article-title":"Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: involvement of prostaglandins and endocannabinoids","volume":"148","author":"Telleria-Diaz","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2012.02.012_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1476-5381.2010.00703.x","article-title":"Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids","volume":"160","author":"Staniaszek","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2012.02.012_bib0210","first-page":"207","article-title":"Role of sensory nerves in gastroprotective effect of anandamide in rats","volume":"62","author":"Warzecha","year":"2011","journal-title":"J Physiol Pharmacol"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T17:51:16Z","timestamp":1742665876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661812000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1043661812000369"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.02.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}